Morgan Stanley’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.69M | Sell |
|
|||||
|
2025
Q1 | $5.57M | Buy |
|
|||||
|
2024
Q4 | $4.56M | Sell |
|
|||||
|
2024
Q3 | $9.26M | Buy |
|
|||||
|
2024
Q2 | $1.14M | Buy |
|
|||||
|
2024
Q1 | $1M | Sell |
|
|||||
|
2023
Q4 | $1.18M | Buy |
|
|||||
|
2023
Q3 | $318K | Buy |
|
|||||
|
2023
Q2 | $407K | Sell |
|
|||||
|
2023
Q1 | $648K | Buy |
|
|||||
|
2022
Q4 | $761K | Buy |
|
|||||
|
2022
Q3 | $295K | Sell |
|
|||||
|
2022
Q2 | $1.01M | Sell |
|
|||||
|
2022
Q1 | $1.35M | Sell |
|
|||||
|
2021
Q4 | $9.26M | Buy |
|
|||||
|
2021
Q3 | $6.37M | Buy |
|
|||||
|
2021
Q2 | $408K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $110K | Buy |
|